Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Revista Ciências em Saúde |
Texto Completo: | https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009 |
Resumo: | Coronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence. |
id |
RCS_c4e0cd420315def4aad27d6fe47f630f |
---|---|
oai_identifier_str |
oai:ojs.portalrcs.hcitajuba.org.br:article/1009 |
network_acronym_str |
RCS |
network_name_str |
Revista Ciências em Saúde |
repository_id_str |
|
spelling |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of careTreinamento por simulação como resposta à demanda dos pacientes críticos COVID19: segurança e qualidade na assistênciaCOVID-19pandemicCOVID-19pandemiaCoronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence. A Coronavirus Disease (COVID-19), também denominada por severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), foi descrita pela primeira vez no mês de dezembro de 2019, em Wuhan, na China. Esta disseminou-se por todos os continentes, tendo sido declarada pela Organização Mundial da Saúde (OMS), em 11 de março de 2020, como uma pandemia global. No dia 24de junho de 2020, estavam reportados pela OMS 9.129.146 casos e 473.797 mortes causadas pelo SARS-CoV-2/COVID 19. A transmissão do vírus é feita através de gotículas, embora tenha sido encontrado também nas fezes e no sangue, admitindo-se assim, outros meios de potencial transmissão. A sintomatologia associada à infeção por SARS-CoV -2 inclui a presença de febre, mialgia ou fadiga, tosse produtiva e/ou tosse não produtiva dispneia, fadiga ou mialgias na maioria dos casos. Existem ainda relatados de sintomas como a cefaleia, dor de garganta, hemoptises e sintomas gastrointestinais como a diarreia, náusea e dor abdominal, mas com menor incidência.AISI/HCI2020-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionInvited articleArtigo de convidadoapplication/pdfapplication/pdfhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/100910.21876/rcshci.v10i3.1009Revista Ciências em Saúde; v. 10 n. 3 (2020): Julho a Setembro de 2020; 3-4Health Sciences Journal; Vol 10 No 3 (2020): July to September 2020; 3-42236-378510.21876/rcshci.v10i3reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIporenghttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/547https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/550Copyright (c) 2020 REVISTA CIÊNCIAS EM SAÚDEhttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessSouza, Luís Manuel Mota deMarques, Maria do Céu Mendes Pinto2020-12-03T13:40:30Zoai:ojs.portalrcs.hcitajuba.org.br:article/1009Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2020-12-03T13:40:30Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse |
dc.title.none.fl_str_mv |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care Treinamento por simulação como resposta à demanda dos pacientes críticos COVID19: segurança e qualidade na assistência |
title |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care |
spellingShingle |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care Souza, Luís Manuel Mota de COVID-19 pandemic COVID-19 pandemia |
title_short |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care |
title_full |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care |
title_fullStr |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care |
title_full_unstemmed |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care |
title_sort |
Simulation training as a response to the demand of critical patients COVID19: safety and quality of care |
author |
Souza, Luís Manuel Mota de |
author_facet |
Souza, Luís Manuel Mota de Marques, Maria do Céu Mendes Pinto |
author_role |
author |
author2 |
Marques, Maria do Céu Mendes Pinto |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Souza, Luís Manuel Mota de Marques, Maria do Céu Mendes Pinto |
dc.subject.por.fl_str_mv |
COVID-19 pandemic COVID-19 pandemia |
topic |
COVID-19 pandemic COVID-19 pandemia |
description |
Coronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-06-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Invited article Artigo de convidado |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009 10.21876/rcshci.v10i3.1009 |
url |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009 |
identifier_str_mv |
10.21876/rcshci.v10i3.1009 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/547 https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/550 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 REVISTA CIÊNCIAS EM SAÚDE https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 REVISTA CIÊNCIAS EM SAÚDE https://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
AISI/HCI |
publisher.none.fl_str_mv |
AISI/HCI |
dc.source.none.fl_str_mv |
Revista Ciências em Saúde; v. 10 n. 3 (2020): Julho a Setembro de 2020; 3-4 Health Sciences Journal; Vol 10 No 3 (2020): July to September 2020; 3-4 2236-3785 10.21876/rcshci.v10i3 reponame:Revista Ciências em Saúde instname:Hospital de Clínicas de Itajubá instacron:HCI |
instname_str |
Hospital de Clínicas de Itajubá |
instacron_str |
HCI |
institution |
HCI |
reponame_str |
Revista Ciências em Saúde |
collection |
Revista Ciências em Saúde |
repository.name.fl_str_mv |
Revista Ciências em Saúde - Hospital de Clínicas de Itajubá |
repository.mail.fl_str_mv |
rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br |
_version_ |
1797068962807152640 |